Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chitotriosidase 1 is an enzymatically active chitinase belonging to the glycosyl hydrolase family 18 (GH18), produced mainly by human macrophages and neutrophils. Its primary function is the hydrolysis of β-(1,4)-linkages in chitin, a structural component of fungi, insects, and crustaceans. In humans, CHIT1 levels are especially high during macrophage activation and inflammation. It plays a key defensive role against chitin-containing pathogens, largely contributing to the innate immune response. Elevated serum CHIT1 is a well-known biomarker for Gaucher’s disease, and increased expression is noted in diverse inflammatory and fibrotic conditions. CHIT1 is thus both a therapeutic target and a diagnostic biomarker in clinical medicine. Several chitinase inhibitors have been developed to probe its role in diseases and potentially modulate aberrant inflammatory responses.
Chitinase inhibitors block enzymatic breakdown of chitin, potentially suppressing inflammatory pathways linked to disease
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chitotriosidase 1 (CHIT1).